GRITSTONE BIO INCGRITSTONE BIO INCGRITSTONE BIO INC

GRITSTONE BIO INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪95.84 M‬EUR
−1.135EUR
‪−125.47 M‬EUR
‪1.21 M‬EUR
‪97.92 M‬
Beta (1Y)
2.51

About Gritstone bio, Inc.

CEO
Andrew R. Allen
Headquarters
Emeryville
Employees (FY)
231
Founded
2015
FIGI
BBG00M618RX8
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange GRITSTONE BIO INC stocks are traded under the ticker 2JQ.
GRITSTONE BIO INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
2JQ earnings for the last quarter are −0.24 EUR per share, whereas the estimation was −0.30 EUR resulting in a 20.53% surprise. The estimated earnings for the next quarter are −0.30 EUR per share. See more details about GRITSTONE BIO INC earnings.
GRITSTONE BIO INC revenue for the last quarter amounts to ‪9.41 M‬ EUR despite the estimated figure of ‪4.63 M‬ EUR. In the next quarter revenue is expected to reach ‪2.64 M‬ EUR.
Yes, you can track GRITSTONE BIO INC financials in yearly and quarterly reports right on TradingView.
2JQ net income for the last quarter is ‪−27.92 M‬ EUR, while the quarter before that showed ‪−36.36 M‬ EUR of net income which accounts for 23.20% change. Track more GRITSTONE BIO INC financial stats to get the full picture.
No, 2JQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2JQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRITSTONE BIO INC stock right from TradingView charts — choose your broker and connect to your account.
2JQ reached its all-time high on Dec 6, 2018 with the price of 27.210 EUR, and its all-time low was 0.655 EUR and was reached on Apr 22, 2024. View more price dynamics on 2JQ chart.
See other stocks reaching their highest and lowest prices.
As of May 7, 2024, the company has 231.00 employees. See our rating of the largest employees — is GRITSTONE BIO INC on this list?
We've gathered analysts' opinions on GRITSTONE BIO INC future price: according to them, 2JQ price has a max estimate of 9.41 EUR and a min estimate of 2.82 EUR. Watch 2JQ chart and read a more detailed GRITSTONE BIO INC stock forecast: see what analysts think of GRITSTONE BIO INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRITSTONE BIO INC EBITDA is ‪−127.10 M‬ EUR, and current EBITDA margin is ‪−11.05 K‬%. See more stats in GRITSTONE BIO INC financial statements.